You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 150 No. 5, May 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Anti-inflammatory Therapy Reduces Wheezing After Bronchiolitis

Tuna Reijonen, MD; Matti Korppi, MD; Liisa Kuikka, MD; Kyllikki Remes, MD

Arch Pediatr Adolesc Med. 1996;150(5):512-517.


Abstract

Objective
To evaluate whether early anti-inflammatory therapy with nebulized cromolyn sodium or budesonide reduces wheezing after bronchiolitis.

Design and Setting
A randomized, controlled study in a university hospital that provides primary hospital care for all pediatric patients in a defined area.

Patients
One hundred consecutive infants younger than 24 months treated in the hospital for acute bronchiolitis.

Interventions
Thirty-four patients received cromolyn sodium, 20 mg four times a day for 8 weeks and 20 mg three times a day for 8 weeks, and 34 patients received budesonide, 500 µg twice a day for 8 weeks and 250 µg twice a day for 8 weeks, by a foot pump with a face mask; 32 patients in the control group received no therapy.

Main Outcome Measures
Numbers of physician-diagnosed wheezing episodes, hospital admissions for bronchial obstructions, and symptomatic days recorded by the parents.

Results
Children in the cromolyn sodium (19%) and budesonide (16%) groups had significantly fewer physician-diagnosed wheezing episodes than those in the control group (47%) during the second 8-week period (P<.05). A significant reduction in hospital admissions for bronchial obstructions was seen in the budesonide group and in the children with atopy in both treatment groups (P<.05). The children with atopy had significantly more subsequent wheezing episodes and hospital admissions than those without atopy (P<.05). The numbers of symptomatic days did not differ significantly among the three groups.

Conclusions
Early anti-inflammatory therapy with nebulized cromolyn sodium or budesonide reduces the number of wheezing episodes and hospital admissions after bronchiolitis. Children with atopy are at high risk of subsequent wheezing episodes, and they particularly benefit from anti-inflammatory therapy.

(Arch Pediatr Adolesc Med. 1996;150:512-517)



Author Affiliations

From the Department of Pediatrics, Kuopio (Finland) University Hospital.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The effect of high dose inhaled corticosteroids on wheeze in infants after respiratory syncytial virus infection: randomised double blind placebo controlled trial
Ermers et al.
BMJ 2009;338:b897-b897.
ABSTRACT | FULL TEXT  

Inhaled corticosteroids and children.
Kohler et al.
NEJM 2006;355:624-624.
FULL TEXT  

Effect of inhaled steroids on lung function in young children: a cohort study
Devulapalli et al.
Eur Respir J 2004;23:869-875.
ABSTRACT | FULL TEXT  

Pharmacologic Treatment of Bronchiolitis in Infants and Children: A Systematic Review
King et al.
Arch Pediatr Adolesc Med 2004;158:127-137.
ABSTRACT | FULL TEXT  

Allergen-Specific Immunoglobulin E Antibodies in Wheezing Infants: The Risk for Asthma in Later Childhood
Kotaniemi-Syrjanen et al.
Pediatrics 2003;111:e255-261.
ABSTRACT | FULL TEXT  

Relationship between respiratory syncytial virus bronchiolitis and future obstructive airway diseases
Wennergren and Kristjansson
Eur Respir J 2001;18:1044-1058.
ABSTRACT | FULL TEXT  

Treatment and Prevention of Respiratory Syncytial Virus Lower Respiratory Tract Infection . Long-Term Effects on Respiratory Outcomes
SIMOES
Am. J. Respir. Crit. Care Med. 2001;163:S14-17.
FULL TEXT  

Predictors of Asthma Three Years After Hospital Admission for Wheezing in Infancy
Reijonen et al.
Pediatrics 2000;106:1406-1412.
ABSTRACT | FULL TEXT  

Prednisolone Plus Albuterol Versus Albuterol Alone in Mild to Moderate Bronchiolitis
Goebel et al.
CLIN PEDIATR 2000;39:213-220.
ABSTRACT  

Randomised placebo controlled trial of nebulised corticosteroids in acute respiratory syncytial viral bronchiolitis
Cade et al.
Arch. Dis. Child. 2000;82:126-130.
ABSTRACT | FULL TEXT  

Randomised controlled trial of budesonide for the prevention of post-bronchiolitis wheezing
Fox et al.
Arch. Dis. Child. 1999;80:343-347.
ABSTRACT | FULL TEXT  

Anti-inflammatory Therapy Reduces Wheezing After Bronchiolitis-Reply
Reijonen et al.
Arch Pediatr Adolesc Med 1997;151:109-109.
ABSTRACT  

Anti-inflammatory Therapy Reduces Wheezing After Bronchiolitis
Hakim
Arch Pediatr Adolesc Med 1997;151:108-109.
ABSTRACT  

ANTI-INFLAMMATORIES REDUCE WHEEZING AFTER BRONCHIOLITIS
JWatch General 1996;1996:3-3.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.